Reading: Trial of Controversial Alzheimer’s Drug Halted After Disappointing Outcomes

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Outcomes

Last updated: 2024/11/26 at 2:22 AM

Team Article Arena

0 Min Read

Cassava Sciences stated that its drug didn’t considerably scale back cognitive decline in 1,900 individuals with gentle to average Alzheimer’s illness.

Share This Article

Historical Egyptian temple courting again 2,000 years found by archaeologists

Next Article Excessive-Depth Consuming Is Worse Than Binge Consuming

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Outcomes

Latest article

Stanley’s new Messi x Stanley assortment options athlete-focused tumblers

Most Rural Hospitals Have Closed Their Maternity Wards, Research Finds

E.P.A. Once more Seeks Limits on a Dangerous Pesticide

Reward concepts below $50: Luxe present finds for the elegant recipient in your life

Welcome to The Article Arena, your ultimate destination for insightful and engaging articles spanning a multitude of subjects. Our platform was born out of a passion for knowledge-sharing and a commitment to providing valuable content to curious minds around the world.